logo

BCAR

D. Boral ARC I·NASDAQ
--
--(--)
--
--(--)
3.62 / 10
Netural

Fundamental health scores 3.6/10, indicating concerns. Strengths include solid Asset‑MV, high inventory turnover, and decent gross profit margin. Weaknesses are negative ROA, low diluted EPS growth quality, and modest liquidity despite a strong current ratio. Overall fundamentals remain challenging.

Fundamental(3.62)SentimentTechnical

Analysis Checks(9/10)

Inventory turnover ratio
Value103.94
Score2/3
Weight9.22%
1M Return1.58%
Gross profit margin (%)
Value41.83
Score2/3
Weight9.42%
1M Return1.58%
Quick ratio
Value2.28
Score2/3
Weight9.21%
1M Return1.58%
Rate of return on total assets (%)
Value-0.11
Score2/3
Weight9.32%
1M Return1.61%
Fixed assets turnover ratio
Value9306.28
Score2/3
Weight7.50%
1M Return1.28%
Annualized return on total assets (%)
Value-0.11
Score2/3
Weight9.32%
1M Return1.61%
Diluted earnings per share (YoY growth rate %)
Value32.21
Score0/3
Weight5.29%
1M Return0.93%
Asset-MV
Value-0.55
Score2/3
Weight18.06%
1M Return2.96%
Current assets / Total assets (%)
Value0.22
Score3/3
Weight13.09%
1M Return2.34%
Current ratio
Value16.58
Score2/3
Weight9.59%
1M Return1.60%
Is BCAR undervalued or overvalued?
  • BCAR scores 3.62/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 0.00% net margin, 0.00 P/E ratio, 1.50 P/B ratio, and 0.00% earnings growth, these metrics solidify its Netural investment rating.